Literature DB >> 2998021

Nucleotide sequences of the 1B and 1C nonstructural protein mRNAs of human respiratory syncytial virus.

P L Collins, G W Wertz.   

Abstract

The genes encoding the 1C and 1B mRNAs of human respiratory syncytial (RS) virus are first in the order of viral transcription and encode nonstructural (NS) proteins of approximate molecular weights 14,000 and 11,000, respectively, estimated by gel electrophoresis. The complete nucleotide sequences of the 1C and 1B mRNAs determined from several full-length cDNA clones are described. The 1C and 1B mRNAs contain 528 and 499 nucleotides, respectively, exclusive of poly(A), and encode proteins of 139 and 124 amino acids. The calculated molecular weights of the predicted NS1C and NS1B proteins are 15,567 and 14,674, respectively. Both mRNA sequences contain the 5'-terminal sequence, 5' GGGGCAAAU . . . , and the 3'-terminal sequence, 5' . . . AGUAUA(N)1-4-poly(A), that were identified previously as conserved among six other RS viral mRNAs. In addition, a dicistronic readthrough RNA having the general structure 5' 1C mRNA-intergenic sequence-1B mRNA 3' was identified by dideoxynucleotide sequencing of intracellular poly(A)+ RNA using a DNA primer derived from a 1B-cDNA clone. In the dicistronic RNA, the nucleotide sequences of the 1C and 1B cistrons are separated by, in mRNA sense, four A residues and the intergenic sequence 5' . . . CUUAACAGAAGACAAAAAN . . . 3' (N represents unidentified nucleotide). The significance of these sequences is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998021     DOI: 10.1016/0042-6822(85)90384-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s).

Authors:  S Barik
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity.

Authors:  David R McGivern; Peter L Collins; Rachel Fearns
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Evidence that the respiratory syncytial virus polymerase is recruited to nucleotides 1 to 11 at the 3' end of the nucleocapsid and can scan to access internal signals.

Authors:  Vanessa M Cowton; Rachel Fearns
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.

Authors:  P L Atreya; M E Peeples; P L Collins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Molecular cloning of pneumonia virus of mice.

Authors:  P Chambers; J Barr; C R Pringle; A J Easton
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response.

Authors:  J Schlender; B Bossert; U Buchholz; K K Conzelmann
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 8.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.

Authors:  Anne L Hotard; Fyza Y Shaikh; Sujin Lee; Dan Yan; Michael N Teng; Richard K Plemper; James E Crowe; Martin L Moore
Journal:  Virology       Date:  2012-10-11       Impact factor: 3.616

10.  Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.